Condition (MeSH)
Glossitis, Benign Migratory
ClinicalTrials.gov lists 25 trials for Glossitis, Benign Migratory or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
25 of the 25 trials are tagged with Glossitis, Benign Migratory itself; the rest are tagged with a narrower condition beneath it.
When did Glossitis, Benign Migratory trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2023 | 1 |
| 2021 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 3 |
| 2015 | 1 |
| 2013 | 2 |
| 2011 | 3 |
| 2010 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Glossitis, Benign Migratory trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 4 |
| Not applicable | 8 |
| Observational | 12 |
How many Glossitis, Benign Migratory trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 3 |
| Completed | 15 |
| Terminated | 1 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Glossitis, Benign Migratory trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Biocodex | 1 |
| Quidel Corporation | 1 |
Which drugs are being tested for Glossitis, Benign Migratory? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Amoxicillin | 1 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Doxycline | 6 |
| Ceftriaxone 4g/ 24h | 2 |
| Antibiotics | 2 |
| Antibiotic Treatment | 2 |
| EM-amoxicillin 3 x 14 days | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Glossitis, Benign Migratory trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Gastrointestinal symptoms, Photosensitivity | 56 | 1 |
Which publications cover Glossitis, Benign Migratory? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Prevalence of Geographic tongue and Related Predisposing Factors in 7-18 Year-Old Students in Kermanshah, Iran 2014. | Global journal of health science | 2015 | Yes |
| Treatment of erythema migrans with doxycycline for 10 days versus 15 days. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2012 | Yes |
| The prevalence and risk factors associated with benign migratory glossitis lesions in 7619 Turkish dental outpatients. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics | 2009 | Yes |
| Images in clinical medicine. Geographic tongue. | The New England journal of medicine | 2009 | Yes |
| Prevalence and risk factors associated with geographic tongue among US adults. | Oral diseases | 2006 | Yes |
Showing 5 of 7 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.